Denali Therapeutics Inc (DNLI) COM USD0.01
1.35%- This stock can be held in a
Stocks and Shares ISASell:$23.00
Buy:$23.02
Change:
$1.10
(5.04%)
$1.10
(5.04%)Market closed | Prices delayed by at least 15 minutes
Sell:$23.00
Buy:$23.02
Change:$1.10
(5.04%)
$1.10
(5.04%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 7 January 2025 | Ryan J WattsChairman/CEO | Sell Tax related | 7,650 | $20.81 | $159,196.50 | 253,071 |
| 7 January 2025 | Alexander O (Alex) SchuthCFO | Sell Tax related | 2,907 | $20.81 | $60,494.67 | 244,308 |
| 7 January 2025 | Carole HoOther Level A | Sell Tax related | 2,907 | $20.81 | $60,494.67 | 175,673 |
| 7 January 2025 | Steve E. KrognesDirector | Sell Tax related | 3,339 | $20.81 | $69,484.59 | 25,757 |
| 6 January 2025 | Ryan J WattsChairman/CEO | Sell Tax related | 29,266 | $20.22 | $591,758.52 | 260,721 |
| 6 January 2025 | Alexander O (Alex) SchuthCFO | Sell Tax related | 12,255 | $20.22 | $247,796.10 | 247,215 |
| 6 January 2025 | Carole HoOther Level A | Sell Tax related | 12,255 | $20.22 | $247,796.10 | 178,580 |
| 2 January 2025 | Vicki L. SatoChairman of the Board | Sell Regular sell transaction (market) | 3,080 | $20.91 | $64,402.80 | 107,976 |
| 31 December 2024 | Steve E. KrognesDirector | Sell Regular sell transaction (market) | 30,000 | $20.25 | $607,500.00 | 29,096 |
| 11 November 2024 | David P SchenkeinIndependent Director | Sell Regular sell transaction (market) | 27,129 | $32.09 | $870,569.61 | 41,532 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 April 2024 | Steve E. KrognesDirector | Sell Regular sell transaction (market) | 92,500 | $20.50 | $1,896,250.00 | 47,341 |
| 18 October 2024 | Ryan J WattsChairman/CEO | Sell Option/Award related | 40,000 | $27.69 | $1,107,600.00 | 235,807 |
| 11 November 2024 | David P SchenkeinIndependent Director | Sell Option/Award related | 32,312 | $32.87 | $1,062,095.44 | 9,220 |
| 30 September 2024 | Steve E. KrognesDirector | Sell Regular sell transaction (market) | 30,000 | $29.03 | $870,900.00 | 29,096 |
| 11 November 2024 | David P SchenkeinIndependent Director | Sell Regular sell transaction (market) | 27,129 | $32.09 | $870,569.61 | 41,532 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.